Skip to main content

Vanderbilt Ingram Cancer Center

VICC’s annual Cancer Survivors Celebration set for Sept. 10

Aug. 24, 2017—Vanderbilt-Ingram Cancer Center (VICC) will host the 2017 Cancer Survivors Celebration Sunday, Sept. 10, from 2–4 p.m. This year’s free event, offered in partnership with Monroe Carell Jr. Children’s Hospital at Vanderbilt, will be held at the Vanderbilt Student Life Center, 310 25th Ave. South.

Read more


Kidney cancer patient, survivor event set for Sept. 9

Aug. 17, 2017—Vanderbilt-Ingram Cancer Center (VICC) will sponsor an educational conference for kidney cancer patients, survivors and family members Saturday, Sept. 9, 8 a.m. – 2 p.m., in the Preston Research Building, Suite 898.

Read more


Report identifies IT upgrades needed to enhance cancer care

Aug. 17, 2017—A group of nationally recognized medical information and data management experts has recommended the development of new knowledge software applications that work alongside electronic health record systems (EHRs) to help practicing oncologists access and use the latest genomic information to assist in the treatment of cancer patients.

Read more


VUMC listed among top 100 oncology programs by Becker’s Hospital Review

Aug. 15, 2017—Vanderbilt University Medical Center (VUMC) has been named to the Becker’s Hospital Review roster of 100 Hospitals and Health Systems with Great Oncology Programs.

Read more


Cancer patient creates artwork for Radiation Oncology suite

Aug. 10, 2017—In her life, Jessi Zazu, 27, has toured the world as a musician in the group Those Darlins, recorded three studio albums, starred in music videos and exhibited her original artwork in individual and group art shows.

Read more


Breast Cancer Genomic Profiling Reveals Clues to Treatment Resistance

Aug. 9, 2017—Thanks to advances in treatment, the relative five-year survival rate from all combined subtypes of breast cancer now exceeds 90 percent and yet the disease remains the third leading cause of cancer deaths in the United States after lung and colorectal cancers.

Read more


Early drivers of gastric cancer

Aug. 8, 2017—Using bioinformatics approaches, Vanderbilt investigators have identified gene expression networks that are deregulated in mouse and human stomach cancers.

Read more


Shinohara’s life and career defined by curiosity

Aug. 3, 2017—Curiosity is the spark that has always energized and illuminated Eric Shinohara’s life — curiosity about the natural world, about other people and about how to help those individuals.

Read more


Investigators match novel cancer mutations with potential therapies

Aug. 3, 2017—Research led by Vanderbilt-Ingram Cancer Center (VICC) investigators may have solved a mystery about why a targeted therapy stops working in a small group of breast cancer patients.

Read more


Nashville Sounds partner with VICC for cancer awareness

Aug. 3, 2017—The Nashville Sounds baseball team recently highlighted cancer care at Vanderbilt-Ingram Cancer Center (VICC) during a special “Cancer Awareness Night.”

Read more


Study identifies protein’s role in chemotherapy resistance

Jul. 20, 2017—Researchers at Vanderbilt University Medical Center (VUMC) have discovered a protein that may lead to a new way to prevent resistance and improve outcomes for patients whose cancers have mutations in the tumor suppressor gene BRCA2.

Read more


Arteaga to direct UT Southwestern cancer center

Jul. 13, 2017—Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies (C2T2), director of the Breast Cancer Research Program and associate director for Clinical Research at Vanderbilt-Ingram Cancer Center (VICC), has been named director of the Harold C. Simmons Comprehensive Cancer Center and associate dean of Oncology Programs at the UT Southwestern Medical Center in Dallas.

Read more


Upcoming Events

MORE EVENTS »